Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Top Investors Are Abandoning Shire PLC (SHPG) in Droves

Page 1 of 2

Hedge funds may not always be right, even collectively, but data shows that their consensus long positions have historically outperformed broader market benchmarks. For example, the Goldman Sachs’ VIP list, which includes the 50 stocks that appear the most often among hedge funds’ top-10 largest holdings, has beaten the S&P 500 gauge on a quarterly basis 64% of the time since 2001, including last year, when it delivered impressive 23% returns in a flat market. Meanwhile, Goldman Sachs’ list of the 20 ‘Most Concentrated’ stocks, which hedge funds own the highest percentage of in terms of the stock’s float, has gained 18% this year to the S&P 500’s 8% gains. Clearly, it’s worthwhile to pay attention to what hedge funds are buying, so let’s check out the latest 13F filing data to see what they think about Shire PLC (ADR) (NASDAQ:SHPG).

Shire PLC (ADR) (NASDAQ:SHPG) investors should be aware of a large decrease in activity from the world’s largest hedge funds in recent months. SHPG was in 50 hedge funds’ portfolios at the end of September. There were 64 hedge funds in our database with SHPG holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Signature Bank (NASDAQ:SBNY), Allegion PLC (NYSE:ALLE), and Mallinckrodt PLC (NYSE:MNK) to gather more data points.

Follow Shire Plc
Trade (SHPGY) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

people, person, lab, nuclear, hydrogen, concept, chemistry, technicians, researching, formula, chemists, biotechnology, researchers, discovery, weapon, samples,

Syda Productions/Shutterstock.com

How have hedgies been trading Shire PLC (ADR) (NASDAQ:SHPG)?

At Q3’s end, a total of 50 of the hedge funds tracked by Insider Monkey were bullish on this stock, a 22% slide from the second quarter of 2016. That came after a large jump in the second quarter, putting hedge fund ownership back near where it was on March 31. With hedgies’ capital changing hands, there exists a select group of noteworthy hedge fund managers who were increasing their stakes meaningfully (or already accumulated large positions).
SHPG
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Paulson & Co, managed by John Paulson, holds the largest position in Shire PLC (ADR) (NASDAQ:SHPG). Paulson & Co has a $904.9 million position in the stock, comprising 9.8% of its 13F portfolio. Coming in second is Lone Pine Capital, managed by Stephen Mandel, which holds a $328.5 million position. Remaining members of the smart money that hold long positions include Samuel Isaly’s OrbiMed Advisors, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, and Jacob Doft’s Highline Capital Management.

Page 1 of 2
Loading Comments...